Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Family & Advocates
- Remove Public Health Professionals
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Spanish Speakers
- Remove Withdrawal
- Remove Opioid Use Disorder
- Remove Opioids or Opiates
- Remove Buprenorphine
- Remove Opium
- Remove Over-the-Counter Drugs
- Remove Pain Relievers
- Remove Medication-Assisted Treatment
- Remove Treatment Planning
- Remove Primary Care
Main page content
Published: December 2021
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: December 2015
This Korean-language brochure gives patients information on buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.
Published: March 2015
This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.